Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05600036

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Conditions: Plaque Psoriasis

Sex: All

Ages: 18 Years – 75 Years

Phase: PHASE2

Enrollment: 210

Sponsor: Alumis Inc

Location: United States

Summary

This is a multi-center, randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis.

Eligibility Criteria

Inclusion Criteria:Total body weight >40 kg (88 lb)Men and woman age 18-75Men and Women must use highly effective methods of contraception for the entirety of the studyExclusion Criteria:History of malignancy within the last 5 yearsPositive for HIV, Hepatitis B or CHistory of tuberculosisDiagnosis of non-plaque psoriasisPatients with QTcF >450 msec (males) or >470 msec (females) at screeningLive vaccines

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05600036). StuddyBuddy aggregates publicly available trial information.